| Bioactivity | JNJ-26990990 is a broad-spectrum antiepileptic agent with oral activity. JNJ-26990990 can inhibit voltage-gated Na+ channels and N-type Ca2+ channels, but has a very weak inhibitory effect on human carbonic anhydrase-II (IC50 = 110 μM)[1]. |
| CAS | 877316-38-6 |
| Formula | C9H10N2O2S2 |
| Molar Mass | 242.32 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Parker MH, et al. Novel, broad-spectrum anticonvulsants containing a sulfamide group: advancement of N-((benzo[b]thien-3-yl)methyl)sulfamide (JNJ-26990990) into human clinical studies. J Med Chem. 2009;52(23):7528-7536. |
JNJ-26990990
CAS: 877316-38-6 F: C9H10N2O2S2 W: 242.32
JNJ-26990990 is a broad-spectrum antiepileptic agent with oral activity. JNJ-26990990 can inhibit voltage-gated Na+ chan
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.